Skip to main content
Equibles

OAKTREE CAPITAL MANAGEMENT LP

Position in BTAIQ — BioXcel Therapeutics, Inc.

CIK 949509 LOS ANGELES, CA
Back to BTAIQ Full portfolio

Position in BTAIQ

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,946,149
+$1,622,958 QoQ
Shares Held
1,380,248
+472.3% QoQ
Ownership
4.41%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2
of 47 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BTAIQ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

OAKTREE CAPITAL MANAGEMENT LP holds $253,707,210 across 3 Drug Manufacturers - Specialty & Generic names. BTAIQ ranks #2 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INDV
Indivior Pharmaceuticals, Inc.
 6,127,212 $251,399,508
2 BTAIQ
BioXcel Therapeutics, Inc.
This page 		1,380,248 $1,946,149
3 ALVO
Alvotech
 4,764,649 $361,553

All Filings in BTAIQ

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,946,149 1,380,248
2025-12-31 $385,900 241,188
2025-09-30 $617,441 241,188
2025-06-30 $436,550 241,188